Inovio Pharmaceuticals
INO
#9104
Rank
A$0.16 B
Marketcap
A$2.44
Share price
2.99%
Change (1 day)
-30.36%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -A$0.17 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are A$0.18 Million. In 2024 the company made an earning of -A$0.16 Billion, an increase over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.17 Billion10.22%
2024 -A$0.16 Billion-20.03%
2023 -A$0.19 Billion-51.56%
2022 -A$0.4 Billion-8.26%
2021 -A$0.43 Billion95.4%
2020 -A$0.22 Billion36.62%
2019 -A$0.16 Billion20.19%
2018 -A$0.14 Billion10.94%
2017 -A$0.12 Billion9.59%
2016 -A$0.11 Billion118.9%
2015 -A$50.02 Million-10.67%
2014 -A$55.99 Million83.32%
2013 -A$30.54 Million
2011 -A$31.51 Million15.64%
2010 -A$27.25 Million37.7%
2009 -A$19.79 Million2.19%
2008 -A$19.37 Million-14.09%
2007 -A$22.54 Million19.12%
2006 -A$18.92 Million9.62%
2005 -A$17.26 Million5.77%
2004 -A$16.32 Million73.08%
2003 -A$9.43 Million12.75%
2002 -A$8.37 Million
2000 -A$12.66 Million53.93%
1999 -A$8.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.92 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.17 B-15,227.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.80 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.01 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.73 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.21 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-A$3.91 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$0.19 B-230.35%๐Ÿ‡บ๐Ÿ‡ธ USA